Terapia de reconstrucción del sentido asistida por ayahuasca como un recurso temprano para el duelo: un ensayo

Oscar Soto-Angona1,2,3,4, Oscar Andión5, Pablo Sabucedo6

  • 1Department of Psychiatry and Forensic Medicine, Universitat Autonoma de Barcelona, Cerdanyola del Vallés, Spain.

Scientific reports
|September 1, 2025
PubMed
Resumen

La terapia de reconstrucción del sentido asistida por ayahuasca (A-MR) es prometedora para reducir los síntomas graves de duelo. Este estudio encontró que A-MR es seguro y más efectivo que la terapia sola o ningún tratamiento para aliviar el dolor.

Videos de Conceptos Relacionados

Bonanno's Theory of Grieving01:17

Bonanno's Theory of Grieving

Grieving is a complex psychological and emotional process that varies significantly among individuals. George Bonanno's research on bereavement identified four distinct patterns of grieving, offering a nuanced understanding of how people cope with significant loss, such as the death of a spouse, over extended periods. These patterns — resilience, recovery, chronic dysfunction, and delayed grief — highlight the diversity in emotional responses and adaptive mechanisms.
Resilience
155
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
182
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260